ARTICLE | Clinical News
Simbrinza brinzolamide/brimonidine tartrate regulatory update
August 11, 2014 7:00 AM UTC
Novartis’ Alcon Inc. ophthalmic unit said the European Commission approved an MAA for Simbrinza brinzolamide/brimonidine tartrate to reduce intraocular pressure (IOP) in adults with open-angle glauco...